Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Mulu Tesfay to Oncolytic Virotherapy

This is a "connection" page, showing publications Mulu Tesfay has written about Oncolytic Virotherapy.

 
Connection Strength
  
 
 
0.757
  
  1. Tesfay MZ, Kirk AC, Hadac EM, Griesmann GE, Federspiel MJ, Barber GN, Henry SM, Peng KW, Russell SJ. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. J Virol. 2013 Apr; 87(7):3752-9.
    View in: PubMed
    Score: 0.405
  2. Omolekan TO, Folahan JT, Tesfay MZ, Mohan H, Dutta O, Rahimian L, Ferdous KU, Ghavimi R, Cios A, Beng TK, Francis J, D'Auvergne O, Borad MJ, Kousoulas KG, DiGiuseppe S, Nagalo BM, Chamcheu JC. Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses. Front Immunol. 2025; 16:1618751.
    View in: PubMed
    Score: 0.243
  3. Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ. Vesiculovirus neutralization by natural IgM and complement. J Virol. 2014 Jun; 88(11):6148-57.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.